Exos Asset Management’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

Exos Asset Management’s Portfolio FLACW Stock Details FLACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$11K	Hold	138,486	–	–	0.01%	269
2022 Q1	$32K	Buy	138,486 +3,554	+3%	+$1.54K	0.01%	271
2021 Q4	$80K	Buy	134,932 +400	+0.3%	+$279	0.04%	268
2021 Q3	$90K	Buy	134,532 +109,532	+438%	+$98.3K	0.05%	302
2021 Q2	$28K	Hold	25,000	–	–	0.01%	648
2021 Q1	$22K	Buy	+25,000	New	+$42.3K	0.02%	325

Other funds holding FLACW

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

DCM

DG Capital Management New York $475M AUM 36.12% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

Exos Asset Management's FLACW Position: Q2 2022 in Review

Exos Asset Management held its Frazier Lifesciences Acquisition Corporation Warrant (FLACW) position steady in Q2 2022 at 138,486 shares worth $11K. The position accounts for 0.01% of the portfolio, ranked #269.

Exos Asset Management first reported a position in FLACW in Q1 2021 and has held it in 6 quarters since. The position peaked at $90K in Q3 2021. 30 funds tracked by Wall St. Rank hold FLACW as of Q2 2022.

Exos Asset Management held 138,486 shares of Frazier Lifesciences Acquisition Corporation Warrant worth $11K as of Q2 2022.
Exos Asset Management left its Frazier Lifesciences Acquisition Corporation Warrant share count unchanged in Q2 2022.
Frazier Lifesciences Acquisition Corporation Warrant made up 0.01% of Exos Asset Management's portfolio in Q2 2022, its #269 holding.
Exos Asset Management first reported a position in Frazier Lifesciences Acquisition Corporation Warrant in Q1 2021 and has held it in 6 quarters since.
Exos Asset Management's Frazier Lifesciences Acquisition Corporation Warrant position peaked at $90K in Q3 2021.
30 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Warrant as of Q2 2022.

Based on Exos Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.